On Wednesday, Shares of Freeport-McMoRan Inc. (NYSE:FCX), lost -0.99% to $21.08, after a miserable decline (down 60 percent over the last year). However, there may have been a successful hold of resistance at $24.15 by the bears at the starting of May. Since then, the stock has been in tumble mode with prices closing out Tuesday at $21.29.
Freeport-McMoRan Inc., a natural resource company, engages in the acquisition of mineral assets, and oil and natural gas resources. It primarily explores for copper, gold, molybdenum, cobalt, silver, and other metals, in addition to oil and gas.
Shares of Johnson & Johnson (NYSE:JNJ), declined -0.35% to $102.85, during its last trading session.
At a meeting with industry analysts, senior leaders from the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) will declare plans to file for regulatory approval of more than 10 new products between 2015 and 2019, each with the potential to exceed $1 billion in revenue, in addition to more than 40 line extensions of existing and new medicines.
With a portfolio focused on five core therapeutic areas – Immunology, Infectious Diseases & Vaccines, Neuroscience, Cardiovascular & Metabolism and Oncology – the Pharmaceutical segment of Johnson & Johnson (JNJ) is delivering transformational new medicines for unmet medical needs worldwide. Janssen has launched 14 new products since 2009, seven of which already exceed or are on track to achieve sales in excess of $1 billion during 2015.2 These new products, coupled with core growth brands, have fueled industry-leading sales growth and contributed significantly to the earnings growth of Johnson & Johnson. The combined strength of Janssen’s in-market portfolio and robust near-term pipeline provides the momentum to sustain above-industry compound annual growth through 2019.
Johnson & Johnson, together with its auxiliaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
At the end of Wednesday’s trade, Shares of Omnicare Inc. (NYSE:OCR), gained 2.48% to $94.63, hitting its highest level.
Today, Omnicare declared that it plans to adjourn its Annual Meeting of Stockholders when it is held on Thursday, May 21, 2015 at 9:00 a.m. in order to afford the Company’s stockholders time to consider the recent developments involving the Company as formerly declared. The Annual Meeting will reconvene on Monday, June 1, 2015 at 9:00 a.m. at the Renaissance Hotel, 36 East Fourth Street, Cincinnati, Ohio. The record date for stockholders entitled to vote at the Annual Meeting remains March 31, 2015. Proxies formerly presented in respect of the meeting will be voted at the reconvened meeting, unless properly revoked.
Omnicare, Inc. operates as a healthcare services company that specializes in the administration of pharmaceutical care in the United States. The company’s Long-Term Care Group segment offers pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities; and chronic care facilities and other settings.
Finally, InterCloud Systems, Inc. (NASDAQ:ICLD), ended its last trade with 2.07% gain, and closed at $3.45.
On May 15, InterCloud Systems declared that InterCloud Systems, Inc. has been recognized as a Gold Partner by industry leading Wireless Network solutions provider, Aruba Networks. This status is awarded to partners who achieve the highest levels of technical proficiency with the entire Aruba product portfolio, in addition to certain sales benchmarks annually. In addition to Gold Status, InterCloud has also achieved technical certifications to sell and install Aruba’s ClearPass Access Administration Solution, an award winning solution that gives customers control of their networks and enables them to stay secure and manage the Bring Your Own Device (BYoD) trend in the workplace of tomorrow. InterCloud has made substantial investments in the Aruba partnership, and is developing cutting edge Cloud based administration solutions around the product portfolio.
InterCloud Systems, Inc. provides end-to-end IT and network solutions to the telecommunications service provider and corporate enterprise markets through cloud platforms and professional services in the United States and internationally. It operates through three segments: Applications and Infrastructure, Professional Services, and Cloud and Managed Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
